F. E. Zwaan

2.4k total citations
51 papers, 1.8k citations indexed

About

F. E. Zwaan is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, F. E. Zwaan has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 14 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in F. E. Zwaan's work include Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (16 papers) and Cytomegalovirus and herpesvirus research (11 papers). F. E. Zwaan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (16 papers) and Cytomegalovirus and herpesvirus research (11 papers). F. E. Zwaan collaborates with scholars based in Netherlands, Switzerland and France. F. E. Zwaan's co-authors include Jan W. Gratama, J. J. van Rood, B Speck, Els Goulmy, Aloïs Gratwohl, R. Willemze, Ingemar Ernberg, M. A. P. Oosterveer, Els Blokland and George Klein and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

F. E. Zwaan

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. E. Zwaan Netherlands 23 1.1k 471 465 432 295 51 1.8k
R Powles United Kingdom 24 831 0.7× 265 0.6× 464 1.0× 548 1.3× 292 1.0× 67 1.8k
M Banaji United States 14 1.7k 1.5× 475 1.0× 536 1.2× 646 1.5× 306 1.0× 22 2.5k
L Fisher United States 12 1.1k 1.0× 560 1.2× 362 0.8× 390 0.9× 162 0.5× 16 1.7k
HM Shulman United States 18 1.1k 1.0× 501 1.1× 532 1.1× 393 0.9× 176 0.6× 24 1.8k
Shigesaburo Miyakoshi Japan 26 982 0.9× 370 0.8× 596 1.3× 416 1.0× 210 0.7× 90 1.7k
A.H. Filipovich United States 23 1.2k 1.1× 922 2.0× 520 1.1× 297 0.7× 209 0.7× 47 2.0k
Nicola Mordini Italy 23 1.2k 1.0× 338 0.7× 449 1.0× 387 0.9× 226 0.8× 52 1.7k
UW Schaefer Germany 17 894 0.8× 330 0.7× 330 0.7× 248 0.6× 142 0.5× 35 1.3k
D. B. Amos United States 22 1.3k 1.1× 696 1.5× 349 0.8× 179 0.4× 392 1.3× 48 2.0k
Takaharu Matsuyama Japan 17 640 0.6× 232 0.5× 711 1.5× 426 1.0× 146 0.5× 34 1.4k

Countries citing papers authored by F. E. Zwaan

Since Specialization
Citations

This map shows the geographic impact of F. E. Zwaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. E. Zwaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. E. Zwaan more than expected).

Fields of papers citing papers by F. E. Zwaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. E. Zwaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. E. Zwaan. The network helps show where F. E. Zwaan may publish in the future.

Co-authorship network of co-authors of F. E. Zwaan

This figure shows the co-authorship network connecting the top 25 collaborators of F. E. Zwaan. A scholar is included among the top collaborators of F. E. Zwaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. E. Zwaan. F. E. Zwaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mei‐Jie, Michele Baccarani, Robert Peter Gale, et al.. (1997). Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. British Journal of Haematology. 99(1). 23–29. 2 indexed citations
2.
Ljungman, Per, Théo de Witte, Gösta Gahrton, et al.. (1993). Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA‐typing. British Journal of Haematology. 84(1). 61–66. 33 indexed citations
3.
Gratwohl, Aloïs, J. Hermans, Anja van Biezen, et al.. (1993). Splenic Irradiation before Bone Marrow Transplantation for Chronic Myeloid Leukemia: Update of a Prospective Randomized Study. Leukemia & lymphoma. 11(sup1). 227–231. 3 indexed citations
4.
5.
Vlasveld, Lodewijk Th., F. E. Zwaan, Willem E. Fibbe, et al.. (1991). Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: A potentiating role for amsacrine. Annals of Hematology. 62(4). 129–134. 27 indexed citations
6.
Barrett, A. John, Franco Locatelli, J. Treleaven, et al.. (1991). Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY. British Journal of Haematology. 79(4). 567–574. 82 indexed citations
7.
Boström, Lennart, et al.. (1990). A EUROPEAN MULTICENTER STUDY OF CHRONIC GRAFT-VERSUS-HOST DISEASE. Transplantation. 49(6). 1100–1104. 46 indexed citations
8.
Löwenberg, Bob, AW Dekker, Roel Willemze, et al.. (1990). Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study.. Journal of Clinical Oncology. 8(2). 287–294. 112 indexed citations
9.
Gratama, Jan W., M. A. P. Oosterveer, J. J. van Rood, et al.. (1990). SEROLOGICAL AND MOLECULAR STUDIES OF EPSTEIN-BARR VIRUS INFECTION IN ALLOGENEIC MARROW GRAFT RECIPIENTS. Transplantation. 49(4). 725–730. 31 indexed citations
10.
Fibbe, Willem E., Erik W.A. Marijt, W. F. J. Veenhof, et al.. (1990). Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. The Lancet. 335(8682). 131–134. 86 indexed citations
11.
12.
Jiwa, Natasha, Anton K. Raap, Frans M. van de Rijke, et al.. (1989). RAPID DETECTION OF HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF VIREMIC TRANSPLANT RECIPIENTS BY THE POLYMERASE CHAIN REACTION. Transplantation. 48(1). 72–76. 190 indexed citations
13.
Hermans, J., Stefan Suciu, T. Stijnen, et al.. (1989). Treatment of acute myelogenous leukemia. European Journal of Cancer and Clinical Oncology. 25(3). 545–550. 41 indexed citations
14.
Peters, W, R. Willemze, F. E. Zwaan, & L. P. Colly. (1988). Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia. Annals of Hematology. 57(2). 91–95. 7 indexed citations
15.
Goulmy, Els, et al.. (1985). Host-directed cytotoxic activity in bone marrow-grafted patients.. Transplantation Proceedings. 17. 725–726. 5 indexed citations
16.
Gratama, J. W., Anneke Brand, J Jansen, et al.. (1984). Factors influencing platelet survival during antilymphocyte globulin treatment. British Journal of Haematology. 57(1). 5–15. 1 indexed citations
17.
Goulmy, Els, Jan W. Gratama, Els Blokland, F. E. Zwaan, & J. J. van Rood. (1983). MHC restricted cytotoxic T lymphocytes recognize a human transplantation antigen.. Experimental Hematology. 11. 67–69. 1 indexed citations
18.
Broek, P.J. van den, J.W.M. van der Meer, P. C. J. Leijh, et al.. (1981). Functions of granulocytes after allogeneic bone marrow transplantation. Annals of Hematology. 42(4). 253–257. 6 indexed citations
19.
Sabbe, L., Frans H.J. Claas, H. L. Haak, et al.. (1981). Anti-thymocyte globulin (ATG) can eliminate platelet refractoriness. Annals of Hematology. 42(6). 331–335. 6 indexed citations
20.
Tricot, Guido, F. E. Zwaan, Robert H. Kauffmann, J Jansen, & H. L. Haak. (1981). Extreme Potassium Loss in a Patient with Severe Graft Versus Host Disease. Scandinavian Journal of Haematology. 25(3). 264–267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Powles Breakdown of academic impact, for papers by M Banaji Breakdown of academic impact, for papers by L Fisher Breakdown of academic impact, for papers by HM Shulman Breakdown of academic impact, for papers by Shigesaburo Miyakoshi Breakdown of academic impact, for papers by A.H. Filipovich Breakdown of academic impact, for papers by Nicola Mordini Breakdown of academic impact, for papers by UW Schaefer Breakdown of academic impact, for papers by D. B. Amos Breakdown of academic impact, for papers by Takaharu Matsuyama
Rankless by CCL
2026